2 11 40 3d 3d 40 8 16 35 43 2b8 21 1a e 76 Dina Jacobs | Department of Neurology | Perelman School of Medicine at the University of Pennsylvania 62 4d 65 48 48 54 4e 52 5f 41 43 52 5b 7e 7a 88 59 55 4e 5f 57 4b 10 13 58 94 88 1e9 9 10e 3c 1f
a
11 12
1a 8
b
48 8
12
1f 12
1a
20
49 16
19
1b
79 faculty photo 2e

Dina Jacobs, M.D.

6d
Professor of Neurology at the Hospital of the University of Pennsylvania
28
bb
Clinical Director, Penn MS and Related Disorders Program , Perelman School of Medicine at the Hospital of the University of Pennsylvania 7
e3
Director, Community Outreach and Network Development, Penn MS and Related Disorders Program , Perelman School of Medicine at the Hospital of the University of Pennsylvania
69
Neuroscience MS Disease Team Lead , Penn Medicine
8c
Clinical Director, Center for Neuroinflammation and Neurotherapeutics, Penn Medicine
6d
Neurology Clinical Outpatient Director, Penn Medicine
90
Neurology Outpatient Clinical Director, Practice Based Leadership Program, Penn Medicine
11
3 60
Department: Neurology
4 1 b
1d
46 Contact information
45
Department of Neurology
32 Hospital of the University of Pennsylvania
1a 3400 Spruce Street
38 3 West Gates Building
Philadelphia, PA 19104
26
30 Office: (215) 662-3647
34 Fax: (215) 349-5579
24
f
4 3 3 3 2 4 b 1f
13 Education:
21 9 B.A. 25 (Natural Science, Spanish) c
34 University of Pennsylvania , 1990.
21 9 M.D. c
33 University of Pennsylvania, 1996.
c
3 3 21
1f Post-Graduate Training
24 76 Intern, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, 1996-1997.
24 79 Resident, Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia, 1997-2000.
24 73 Fellow, Multiple Sclerosis, Hospital of the University of Pennsylvania, Philadelphia , 2000-2001.
24 a4 Clinical Instructor, Divisions of Multiple Sclerosis and Neuro-Ophthalmology, Hospital of the University of Pennsylvania, Philadelphia, 2000-2002.
24 8a Fellow, Neuro-Ophthalmology , Hospital of the University of Pennsylvania, Scheie Eye Institute, Philadelphia, 2001-2002.
c
3 25
17 Certifications
28 26 American Board of Psychiatry and b Neurology 16 , 2001.
28 26 American Board of Psychiatry and 30 Neurology; Recertification, 2011.
28 26 American Board of Psychiatry and 30 Neurology; Recertification, 2022.
c
3 8b Permanent link
2 29
 
1d
25
21
b6 > Perelman School of Medicine   > Faculty   > Details a
1e 1d
2b 29
23

Selected Publications

12c Pfister A, Desai N, Lane C, Sweeney Smith M, Sekella N, Zimmerman V, Jacobs D: Virtual Dance Program for Multiple Sclerosis: Feasibility, Quality of Life, and Motor Imagery Outcomes. International Journal of MS Care July 2025.

281 Saylor D, Rijke N, McDonell J, Laurson-Doube J, Avasarala J, Baldin E, Banerjee TK, Bogdanovic I, Bove R, Chawla DK, Costello K, Del Giovane C, Abkari NE, Filippini G, Foschi M, Gonzalez-Lorenzo M, Helme A, Jacobs D, Kalincik T, Mantel-Teeuwisse A, Minozzi S, Navas C, Nonino F, Ojo OO, Ozcan B, Pasi E, Peryer G, Prato Chichiraldi A, Ridley B, Sokhi DS, Traboulsee A, Tramacere I, Tye JS, Vecchi S, Viswanathan S, Xie F, Zeineddine M, Schunemann H, Piggott T. : Recommendations for essential medicines for multiple sclerosis in low-resource settings. Mult Scler 2025.

fb Sekella N, Gilmore H, French E, Zimmerman V, Jacobs D, Narula S. : Developing and Piloting a Dedicated Support Group for Young Adults With Multiple Sclerosis. Int J MS Care 2025.

199 Cooper EC, Schindler MK, Bar-Or A, Brandstadter RB, Calkins ME, Gur R, Jacobs DA, Markowitz C, Moore T, Naydovich LR, Perrone CM, Ruparel K, Spangler BC, Troyan S, Shinohara RT, Satterthwaite TD, Baller EB.: Investigating mood and cognition in people with multiple sclerosis: a prospective cross-sectional study protocol. BMJ Open 2025.

223 Hamilton KW, Hua E, Dutcher L, Fernandez Lynch H, Junker P, Doucette AG, Werner D, Kannel EZ, Civitello T, Gabriel P, Ahya VN, Jacobs DA, Garfall A, Pratz K, O Degnan K, Blumberg EA, Capozzi D, Craig E, Takach P, Payne AS, Geara A, Koenig H, Holzman L, Tebas P.: Implementation of an Approach to Equitable Allocation of SARS-CoV-2 Monoclonal Antibodies for Preexposure Prophylaxis: Experience from a Single Medical Center. Open Forum Infectious Diseases 11(8), August 2024.

107 Garabedian M, Pileggi C, Zimmerman V, Jacobs D.: Benefits of a newly diagnosed visit with a MS certified nurse practitioner Consortium of MS Centers Annual Meeting, Nashville, TN May 2024.

158 Rivera Torres N, Lavietes J, Morrison A, Desai N, Jacobs D, Samudralwar R: Identifying if Disparities in Care Exist for Patients with Multiple Sclerosis Recently Hospitalized and Followed in Neurology Resident Clinics Compared to Attending Subspecialty Clinics within a Comprehensive MS Center 59 Consortium of MS Centers Annual Meeting, Nashville, TN May 2024.

111 Bourgeon DA, Desai N, Prout JT, Lane C, Zimmerman V,Jacobs D: How Grit Affects Quality of Life in Individuals with Multiple Sclerosis. Consortium of MS Centers Annual Meeting, Nashville, TN May 2024.

182 Zuroff L, Wijangco J, Brandstadter R, Goldman MD, Graham EL, Farber RS, Freeman L, Valizadeh N, Bove R, Jacobs D: Trends in management practices of seropositive neuromyelitis optica spectrum disorder: Lessons from a multicenter academic cohort. American Academy of Neurology Annual Meeting, Denver, CO April 2024.

118 Johnson TR, Gandelman S, Serafin LR, Charles JY, Jacobs D: Rehabilitation Outcomes in Multiple Sclerosis Patients on Ocrelizumab Diagnosed with West Nile Virus Encephalitis. Cureus 16(3): e57063, March 2024.

2c
7 1d
2c back to top
26 Last updated: 07/17/2025
34 The Trustees of the University of Pennsylvania c
1f
27
24
 
1d
18
1 49 2 8
8
8
8
9
a 8
2c 30 9 7 0